Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vita Life Sciences Limited ( (AU:VLS) ) has issued an update.
Vita Life Sciences Limited, listed on the ASX under the code VLS, is a life sciences company with ordinary fully paid shares that are the subject of an ongoing on-market buy-back program. The release provides an update to its previously notified buy-back, confirming the company continues to actively repurchase shares as part of its capital management strategy.
The latest notification discloses that a total of 721,979 shares had been bought back before the previous trading day, with an additional 68,992 shares repurchased on that previous day. This ongoing on-market buy-back, updated as of 27 March 2026, signals the company’s continuing efforts to manage its share capital and may be interpreted by investors as a sign of confidence in the firm’s valuation and long-term outlook.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited is an Australian-listed company on the ASX under the code VLS, with ordinary fully paid shares on issue. The company operates in the life sciences sector, though the release focuses on its capital management activities rather than specific products or markets.
Average Trading Volume: 14,641
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$140M
Learn more about VLS stock on TipRanks’ Stock Analysis page.

